Peer-influenced content. Sources you trust. No registration required. This is HCN.
MashupMD
Artificial intelligence is poised to significantly advance cardiovascular diagnostics, offering enhanced accuracy in detecting critical conditions from routine electrocardiograms. This promises to refine both diagnostics and patient management in cardiology.
Cardiology April 22nd 2024
The New England Journal of Medicine
Recent findings demonstrate that among patients with small aortic annuli undergoing TAVR, those treated with self-expanding valves experienced significantly lower rates of bioprosthetic-valve dysfunction (9.4%) compared to those with balloon-expandable valves (41.6%), emphasizing the necessity for careful valve selection in clinical practice.
Cardiology April 19th 2024
In a multinational study involving more than 1,500 patients with complex cardiac profiles, findings revealed no statistically significant difference in the primary outcome of death, myocardial infarction, or unplanned revascularization between FFR-guided complete revascularization and culprit-lesion-only PCI over nearly five years of follow-up.
Semaglutide demonstrated a significant reduction in symptoms and weight among heart failure patients with diabetes, highlighted by a 7.3-point greater improvement in the Kansas City Cardiomyopathy Questionnaire clinical summary score compared to placebo.
In a recent randomized, multicenter trial, the use of a microaxial flow pump in addition to standard care resulted in a mortality reduction at 180 days among STEMI patients with cardiogenic shock, with a significant hazard ratio of 0.74.
In a rigorous study involving 6,522 patients, empagliflozin, when administered post-acute myocardial infarction, demonstrated a reduction in first hospitalizations due to heart failure, although it did not significantly alter overall survival rates compared to placebo.